• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对63个智利乳腺癌家族中BRCA1基因18种最常见突变的分子分析。

Molecular analysis of the eighteen most frequent mutations in the BRCA1 gene in 63 Chilean breast cancer families.

作者信息

Jara Lilian, Ampuero Sandra, Santibáñez Eudocia, Seccia Lorena, Rodríguez Juan, Lay-Son Mario Bustamante Guillermo, Ojeda José Manuel, Reyes José Miguel, Blanco Rafael

机构信息

Human Genetics Program, Institute of Biomedical Sciences, School of Medicine, University of Chile, Santiago, Chile.

出版信息

Biol Res. 2004;37(3):469-81. doi: 10.4067/s0716-97602004000300011.

DOI:10.4067/s0716-97602004000300011
PMID:15515971
Abstract

BRCA1 gene mutations account for nearly all families with multiple cases of both early onset breast and/or ovarian cancer and about 30% of hereditary breast cancer. Although to date more than 1,237 distinct mutations, polymorphisms, and variants have been described, several mutations have been found to be recurrent in this gene. We have analyzed 63 Chilean breast/ovarian cancer families for eighteen frequent BRCA1 mutations. The analysis of the five exons and two introns in which these mutations are located was made using mismatch PCR assay, ASO hybridization assay, restriction fragment analysis, allele specific PCR assay and direct sequentiation techniques. Two BRCA1 mutations (185delAG and C61G) and one variant of unknown significance (E1250K) were found in four of these families. Also, a new mutation (4185delCAAG) and one previously described polymorphism (E1038G) were found in two other families. The 185delAG was found in a 3.17% of the families and the others were present only in one of the families of this cohort. Therefore these mutations are not prominent in the Chilean population. The variant of unknown significance and the polymorphism detected could represent a founder effect of Spanish origin.

摘要

BRCA1基因突变几乎存在于所有有早发性乳腺癌和(或)卵巢癌多例的家族中,约占遗传性乳腺癌的30%。尽管迄今为止已描述了1237种以上不同的突变、多态性和变体,但已发现该基因中有几种突变是反复出现的。我们分析了63个智利乳腺癌/卵巢癌家族中的18种常见BRCA1突变。利用错配PCR检测、等位基因特异性寡核苷酸杂交检测、限制性片段分析、等位基因特异性PCR检测和直接测序技术,对这些突变所在的5个外显子和2个内含子进行了分析。在其中4个家族中发现了2种BRCA1突变(185delAG和C61G)以及1种意义不明的变体(E1250K)。此外,在另外2个家族中发现了1种新突变(4185delCAAG)和1种先前描述的多态性(E1038G)。185delAG在3.17%的家族中被发现,其他突变仅在该队列的1个家族中出现。因此,这些突变在智利人群中并不突出。检测到的意义不明的变体和多态性可能代表了西班牙裔的奠基者效应。

相似文献

1
Molecular analysis of the eighteen most frequent mutations in the BRCA1 gene in 63 Chilean breast cancer families.对63个智利乳腺癌家族中BRCA1基因18种最常见突变的分子分析。
Biol Res. 2004;37(3):469-81. doi: 10.4067/s0716-97602004000300011.
2
Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.54个智利乳腺癌/卵巢癌家族中BRCA1和BRCA2突变的发生率及基因型-表型相关性
Breast Cancer Res Treat. 2006 Jan;95(1):81-7. doi: 10.1007/s10549-005-9047-1. Epub 2005 Oct 27.
3
Molecular analysis of the six most recurrent mutations in the BRCA1 gene in 87 Spanish breast/ovarian cancer families.对87个西班牙乳腺癌/卵巢癌家族中BRCA1基因最常见的六种突变进行分子分析。
Cancer Lett. 1998 Jan 30;123(2):153-8. doi: 10.1016/s0304-3835(97)00416-3.
4
BRCA1 mutations in South African breast and/or ovarian cancer families: evidence of a novel founder mutation in Afrikaner families.
Int J Cancer. 2004 Jul 10;110(5):677-82. doi: 10.1002/ijc.20186.
5
BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants.乌拉圭乳腺癌和乳腺癌-卵巢癌家族的 BRCA1 和 BRCA2 种系突变。新突变和未分类变异体的鉴定。
Breast Cancer Res Treat. 2011 Jul;128(1):211-8. doi: 10.1007/s10549-010-1320-2. Epub 2010 Dec 29.
6
[Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women].[突尼斯女性乳腺癌/卵巢癌遗传性易感基因BRCA1的突变分析]
Arch Inst Pasteur Tunis. 2000;77(1-4):11-5.
7
Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.斯洛伐克遗传性乳腺癌和/或卵巢癌家族中的阿什肯纳兹始祖BRCA1/BRCA2突变
Neoplasma. 2006;53(2):97-102.
8
Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed.希腊乳腺癌/卵巢癌家族中的种系BRCA1和BRCA2突变:5382insC是观察到的最常见突变。
Cancer Lett. 2002 Nov 8;185(1):61-70. doi: 10.1016/s0304-3835(01)00845-x.
9
Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families.BRCA1/2 点突变及基因组重排在智利高危乳腺癌/卵巢癌家系中的分布。
Breast Cancer Res Treat. 2011 Apr;126(3):705-16. doi: 10.1007/s10549-010-1170-y. Epub 2010 Sep 22.
10
BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.摩洛哥乳腺癌/卵巢癌家系中的 BRCA1 和 BRCA2 种系突变:新突变和未分类变异。
Gynecol Oncol. 2012 Jun;125(3):687-92. doi: 10.1016/j.ygyno.2012.03.007. Epub 2012 Mar 13.

引用本文的文献

1
Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy.拉美乳腺癌中 DNA 修复基因种系突变的全景:PARP 抑制剂和免疫疗法的机会。
Genes (Basel). 2019 Oct 10;10(10):786. doi: 10.3390/genes10100786.
2
The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.年轻的三阴性乳腺癌墨西哥女性中BRCA1和BRCA2基因突变的患病率。
Breast Cancer Res Treat. 2015 Apr;150(2):389-94. doi: 10.1007/s10549-015-3312-8. Epub 2015 Feb 26.
3
Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
BRCA1和BRCA2基因复发性突变在墨西哥具有显著的临床影响。
Cancer. 2015 Feb 1;121(3):372-8. doi: 10.1002/cncr.29058. Epub 2014 Sep 18.
4
Prevalence and impact of founder mutations in hereditary breast cancer in Latin America.拉丁美洲遗传性乳腺癌中胚系突变的流行情况及其影响。
Genet Mol Biol. 2014 Mar;37(1 Suppl):234-40. doi: 10.1590/s1415-47572014000200009.
5
Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico.波多黎各女性群体中常见的BRCA1和BRCA2基因突变的鉴定。
Cancer Genet. 2012 May;205(5):242-8. doi: 10.1016/j.cancergen.2012.04.002.